Published in Front Microbiol on May 18, 2016
Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol (2004) 18.85
Common virulence factors for bacterial pathogenicity in plants and animals. Science (1995) 11.22
Estimating prokaryotic diversity and its limits. Proc Natl Acad Sci U S A (2002) 9.61
Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature (2002) 9.07
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A (2006) 8.85
An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A (2006) 7.62
Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother (2003) 7.09
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Saccharomyces cerevisiae-based molecular tool kit for manipulation of genes from gram-negative bacteria. Appl Environ Microbiol (2006) 3.51
The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology (2001) 3.37
Pseudomonas-Candida interactions: an ecological role for virulence factors. Science (2002) 3.35
Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A (2004) 3.30
Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol (2007) 3.22
Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol (2003) 3.09
A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol (2004) 3.05
Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. Cell Host Microbe (2015) 2.98
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med (2011) 2.88
Rethinking 'secondary' metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol (2006) 2.86
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Microbial ecology of the cystic fibrosis lung. Microbiology (2007) 2.68
Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa. J Bacteriol (2005) 2.55
The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci U S A (2002) 2.43
Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology (2006) 2.36
The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev (2012) 2.36
Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis. Arch Microbiol (2000) 2.24
Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev (2012) 2.14
Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog (2008) 2.09
Cloning and functional characterization of the Pseudomonas aeruginosa rhlC gene that encodes rhamnosyltransferase 2, an enzyme responsible for di-rhamnolipid biosynthesis. Mol Microbiol (2001) 2.04
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.95
An epidemic Burkholderia cepacia complex strain identified in soil. Lancet (2002) 1.88
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros (2008) 1.71
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61
The role of the microbiome in exacerbations of chronic lung diseases. Lancet (2014) 1.55
Method for rapid detection of cyanogenic bacteria. Appl Environ Microbiol (1983) 1.51
Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A (2012) 1.51
Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One (2013) 1.49
Common themes and variations in the rhodanese superfamily. IUBMB Life (2007) 1.46
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med (2011) 1.43
Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis (2006) 1.39
Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature (2014) 1.36
Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl Environ Microbiol (2008) 1.36
A TEM-2beta-lactamase encoded on an active Tn1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. J Antimicrob Chemother (2000) 1.26
Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol (2001) 1.22
Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature (2015) 1.19
Mechanisms of synergy in polymicrobial infections. J Microbiol (2014) 1.13
Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol (2004) 1.13
Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model. J Bacteriol (2015) 1.13
The cystic fibrosis lung microbiome. Ann Am Thorac Soc (2014) 1.11
Regulation of expression of the cyanide-insensitive terminal oxidase in Pseudomonas aeruginosa. Microbiology (2003) 1.08
Interspecies interaction between Pseudomonas aeruginosa and other microorganisms. Microbes Environ (2013) 1.08
A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence. Infect Immun (2007) 1.07
Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology (2010) 1.07
Concentration-dependent activity of antibiotics in natural environments. Front Microbiol (2013) 1.06
Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response. PLoS One (2012) 1.04
Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains. Microbiology (2010) 1.03
Quorum sensing and policing of Pseudomonas aeruginosa social cheaters. Proc Natl Acad Sci U S A (2015) 1.03
Polybacterial human disease: the ills of social networking. Trends Microbiol (2014) 1.01
The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation. Microbiome (2015) 1.01
Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus. Infect Immun (2014) 1.00
Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions. BMC Microbiol (2008) 1.00
Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol (2004) 0.99
Improved detection of rhamnolipid production using agar plates containing methylene blue and cetyl trimethylammonium bromide. Biotechnol Lett (2009) 0.99
Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia. Eur J Pediatr (1998) 0.99
A gene horizontally transferred from bacteria protects arthropods from host plant cyanide poisoning. Elife (2014) 0.98
Genome Sequence of Burkholderia cenocepacia H111, a Cystic Fibrosis Airway Isolate. Genome Announc (2014) 0.98
Isolation and characterization of mutants defective in the cyanide-insensitive respiratory pathway of Pseudomonas aeruginosa. J Bacteriol (1995) 0.96
Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity. Appl Environ Microbiol (2006) 0.93
Conserved virulence factors of Pseudomonas aeruginosa are required for killing Bacillus subtilis. J Microbiol (2005) 0.92
Bacterial Adaptation during Chronic Respiratory Infections. Pathogens (2015) 0.92
Biosignificance of bacterial cyanogenesis in the CF lung. J Cyst Fibros (2010) 0.90
Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. J Clin Microbiol (2014) 0.90
Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis. J Infect Dis (2010) 0.90
Draft Genome Sequences of Burkholderia cenocepacia ET12 Lineage Strains K56-2 and BC7. Genome Announc (2013) 0.89
2-Heptyl-4-quinolone, a precursor of the Pseudomonas quinolone signal molecule, modulates swarming motility in Pseudomonas aeruginosa. J Bacteriol (2011) 0.87
Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans. Microbiology (2014) 0.86
Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique. J Clin Microbiol (1999) 0.84
Quorum Sensing Protects Pseudomonas aeruginosa against Cheating by Other Species in a Laboratory Coculture Model. J Bacteriol (2015) 0.82
Bacterial cyanogenesis: impact on biotic interactions. J Appl Microbiol (2014) 0.81
Pseudomonas aeruginosa and cyanide production. Eur Respir J (2011) 0.81
Draft Genome Sequence of Burkholderia dolosa PC543 Isolated from Cystic Fibrosis Airways. Genome Announc (2014) 0.81
Real-time monitoring of hydrogen cyanide (HCN) and ammonia (NH₃) emitted by Pseudomonas aeruginosa. J Breath Res (2015) 0.79
Species-specific viability analysis of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus in mixed culture by flow cytometry. BMC Microbiol (2014) 0.78
Investigation of the multifaceted iron acquisition strategies of Burkholderia cenocepacia. Biometals (2015) 0.78
Is hydrogen cyanide a marker of Burkholderia cepacia complex? J Clin Microbiol (2013) 0.78
Cyanide levels found in infected cystic fibrosis sputum inhibit airway ciliary function. Eur Respir J (2014) 0.77